Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Genetic evidence that the differential expression of the ligand-independent isoform of CTLA-4 is the molecular basis of the Idd5.1 type 1 diabetes region in nonobese diabetic mice.

Araki M, Chung D, Liu S, Rainbow DB, Chamberlain G, Garner V, Hunter KM, Vijayakrishnan L, Peterson LB, Oukka M, Sharpe AH, Sobel R, Kuchroo VK, Wicker LS.

J Immunol. 2009 Oct 15;183(8):5146-57. doi: 10.4049/jimmunol.0802610.

2.

Interactions between Idd5.1/Ctla4 and other type 1 diabetes genes.

Hunter K, Rainbow D, Plagnol V, Todd JA, Peterson LB, Wicker LS.

J Immunol. 2007 Dec 15;179(12):8341-9.

3.

The diabetes susceptibility locus Idd5.1 on mouse chromosome 1 regulates ICOS expression and modulates murine experimental autoimmune encephalomyelitis.

Greve B, Vijayakrishnan L, Kubal A, Sobel RA, Peterson LB, Wicker LS, Kuchroo VK.

J Immunol. 2004 Jul 1;173(1):157-63.

4.

Alternative splice forms of CTLA-4 induced by antisense mediated splice-switching influences autoimmune diabetes susceptibility in NOD mice.

Mourich DV, Oda SK, Schnell FJ, Crumley SL, Hauck LL, Moentenich CA, Marshall NB, Hinrichs DJ, Iversen PL.

Nucleic Acid Ther. 2014 Apr;24(2):114-26. doi: 10.1089/nat.2013.0449.

PMID:
24494586
5.

Fine mapping, gene content, comparative sequencing, and expression analyses support Ctla4 and Nramp1 as candidates for Idd5.1 and Idd5.2 in the nonobese diabetic mouse.

Wicker LS, Chamberlain G, Hunter K, Rainbow D, Howlett S, Tiffen P, Clark J, Gonzalez-Munoz A, Cumiskey AM, Rosa RL, Howson JM, Smink LJ, Kingsnorth A, Lyons PA, Gregory S, Rogers J, Todd JA, Peterson LB.

J Immunol. 2004 Jul 1;173(1):164-73.

6.

A SNP in the Immunoregulatory Molecule CTLA-4 Controls mRNA Splicing In Vivo but Does Not Alter Diabetes Susceptibility in the NOD Mouse.

Jakubczik F, Jones K, Nichols J, Mansfield W, Cooke A, Holmes N.

Diabetes. 2016 Jan;65(1):120-8. doi: 10.2337/db15-1175.

7.

The B7-independent isoform of CTLA-4 functions to regulate autoimmune diabetes.

Stumpf M, Zhou X, Bluestone JA.

J Immunol. 2013 Feb 1;190(3):961-9. doi: 10.4049/jimmunol.1201362.

8.

An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells.

Vijayakrishnan L, Slavik JM, Illés Z, Greenwald RJ, Rainbow D, Greve B, Peterson LB, Hafler DA, Freeman GJ, Sharpe AH, Wicker LS, Kuchroo VK.

Immunity. 2004 May;20(5):563-75.

9.

The B10 Idd9.3 locus mediates accumulation of functionally superior CD137(+) regulatory T cells in the nonobese diabetic type 1 diabetes model.

Kachapati K, Adams DE, Wu Y, Steward CA, Rainbow DB, Wicker LS, Mittler RS, Ridgway WM.

J Immunol. 2012 Nov 15;189(10):5001-15. doi: 10.4049/jimmunol.1101013.

10.

Genes within the Idd5 and Idd9/11 diabetes susceptibility loci affect the pathogenic activity of B cells in nonobese diabetic mice.

Silveira PA, Chapman HD, Stolp J, Johnson E, Cox SL, Hunter K, Wicker LS, Serreze DV.

J Immunol. 2006 Nov 15;177(10):7033-41.

11.
12.
13.

Further mapping of the Idd5.1 locus for autoimmune diabetes in NOD mice.

Lamhamedi-Cherradi SE, Boulard O, Gonzalez C, Kassis N, Damotte D, Eloy L, Fluteau G, Lévi-Strauss M, Garchon HJ.

Diabetes. 2001 Dec;50(12):2874-8.

14.

Cellular mechanisms of restored β-cell tolerance mediated by protective alleles of Idd3 and Idd5.

Hamilton-Williams EE, Cheung J, Rainbow DB, Hunter KM, Wicker LS, Sherman LA.

Diabetes. 2012 Jan;61(1):166-74. doi: 10.2337/db11-0790.

15.

CTLA-4-/- mice display T cell-apoptosis resistance resembling that ascribed to autoimmune-prone non-obese diabetic (NOD) mice.

Bergman ML, Cilio CM, Penha-Gonçalves C, Lamhamedi-Cherradi SE, Löfgren A, Colucci F, Lejon K, Garchon HJ, Holmberg D.

J Autoimmun. 2001 Mar;16(2):105-13.

PMID:
11247636
16.

NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans.

Hill NJ, Lyons PA, Armitage N, Todd JA, Wicker LS, Peterson LB.

Diabetes. 2000 Oct;49(10):1744-7.

PMID:
11016460
17.

CT60 genotype does not affect CTLA-4 isoform expression despite association to T1D and AITD in northern Sweden.

Mayans S, Lackovic K, Nyholm C, Lindgren P, Ruikka K, Eliasson M, Cilio CM, Holmberg D.

BMC Med Genet. 2007 Feb 6;8:3.

18.

Roles of CD28, CTLA4, and inducible costimulator in acute graft-versus-host disease in mice.

Li J, Semple K, Suh WK, Liu C, Chen F, Blazar BR, Yu XZ.

Biol Blood Marrow Transplant. 2011 Jul;17(7):962-9. doi: 10.1016/j.bbmt.2011.01.018.

19.

LADA and T1D in Estonian population - two different genetic risk profiles.

Kisand K, Uibo R.

Gene. 2012 Apr 15;497(2):285-91. doi: 10.1016/j.gene.2012.01.089.

PMID:
22326526
20.

Ptpn22 and Cd2 Variations Are Associated with Altered Protein Expression and Susceptibility to Type 1 Diabetes in Nonobese Diabetic Mice.

Fraser HI, Howlett S, Clark J, Rainbow DB, Stanford SM, Wu DJ, Hsieh YW, Maine CJ, Christensen M, Kuchroo V, Sherman LA, Podolin PL, Todd JA, Steward CA, Peterson LB, Bottini N, Wicker LS.

J Immunol. 2015 Nov 15;195(10):4841-52. doi: 10.4049/jimmunol.1402654.

Items per page

Supplemental Content

Support Center